FDA Approves Libervant (diazepam) Buccal Film for the Treatment of Seizure Clusters in Pediatric Patients Ages 2-5 Years

WARREN, N.J., April 29, 2024 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. (NASDAQ: AQST) (“Aquestive” or the“Company”), a pharmaceutical company advancing medicines to bring meaningful improvement to patients ' lives...
Source: Drugs.com - New Drug Approvals - Category: Drugs & Pharmacology Source Type: news